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ABSTRACT
Implants have been considered the treatment of choice to replace missing teeth, unfortunately, peri-implant
disease is still an unresolved issue. Contaminated implants may be decontaminated by physical debridement
and chemical disinfectants; however, there is a lack of consensus regarding the ideal techniques/agents to be
used for the decontamination. The objective of our study was to compare the decontaminating efficacy of
different chemical agents on a titanium surface contaminated with Porphyromonas gingivalis, a typical
representative of the bacterial flora associated with peri-implantitis. Commercially pure Ti grade 4 discs with
a polished surface were treated with a mouthwash containing chlorhexidine digluconate (0.1%), povidone-
iodine (PVP-iodine) solution (10%) or citric acid monohydrate (40%). Qualitative and quantitative assess-
ment of cellular growth and survival were assessed by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) assay and scanning electron microscopy (SEM). Significant differences in the quantity
of P. gingivalis could be observed after 6 days of incubation. A numerical, but not statistically significant (P5
0.066) decrease in the amount of living bacteria was observed in the group treated with the PVP-iodine
solution as compared to the control group. The chlorhexidine (CHX)-treated group presented with
significantly higher cell counts, as compared to the PVP-iodine-treated group (P5 0.032), while this was not
observed compared to the control group and citric acid-treated group. Our results have also been verified by
SEM measurements. Our results suggest that for P. gingivalis contamination on a titanium surface in vitro,
PVP-iodine is a superior decontaminant, compared to citric acid and chlorhexidine-digulconate solution.
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INTRODUCTION
Over the past decades, implants have been considered the
treatment of choice to replace missing teeth, as they have
shown high survival rates (ranging from 90 to 98%) after
being in function for at least 10 years [1–6]. Unfortunately,
subsequent development of peri-implant diseases is still an
unresolved issue [7–10]. Peri-implant infections include
peri-implant mucositis (which can be defined as a reversible
inflammatory response of the peri-implant soft tissues
without bone loss) and peri-implantitis (an inflammatory
process resulting in the loss of supporting bone associated
with suppuration and bleeding) [11–14]. Marginal peri-
implantitis can be traced back to infectious and biome-
chanical factors [15]. One of the key events in the patho-
genesis is the development of microbial colonization on the
surface of the dental implant [16, 17]. Peri-implant in-
fections have mostly been linked to Gram-negative anaer-
obic bacteria [18, 19]; the toxin release by these pathogens
provokes a massive immune response, which causes bone
degradation, ultimately leading to implant loss [20].
Clinical signs of peri-implantitis include increased
probing depths, mucosal recession, fistula formation, sup-
puration, mucosal swelling and bleeding on probing (BOP)
[13, 21, 22]. Once peri-implant disease is diagnosed, the
treating physician will be hard-pressed to deal with this
issue. Various treatment modalities have been suggested and
attempted with the aim of treating this oral pathology. In the
case of peri-implant mucositis, non-surgical mechanical
treatment may be effective and the outcome of therapy may
be further enhanced with the usie of antimicrobial mouth
rinses [11]. However, for peri-implantitis lesions, nonsur-
gical therapy alone was found to be ineffective [23]; for
successful surgical interventions, the contaminated implant
surface must be entirely decontaminated. However, there is a
lack of consensus regarding the techniques/agents to be used
for decontamination [11]. Several agents have been sug-
gested by the literature; nevertheless, citric acid, chlorhexi-
dine (CHX) and povidone-iodine (PVP-iodine) are probably
the most often discussed ones [24, 25].
The objective of our study was to compare the decon-
taminating efficacy of the abovementioned three chemical
agents on polished titanium (Ti) surfaces infected with
Porphyromonas gingivalis, a typical representative of the
bacterial flora associated with peri-implantitis.
MATERIALS AND METHODS
Preparation of Ti implant discs, sample design
During the present study, mechanically polished Ti implant
discs (9 mm in diameter and 2 mm in thickness; commer-
cially pure (CP) Grade 4; Protetim Ltd., Hodmez}ovasarhely,
Hungary) were used. Similarly to the transgingival part of
dental implants, the discs were polished to a surface
roughness not exceeding 0.2 mm [10]. After cleaning in an
ultrasonic bath with acetone, absolute ethanol and distilled
water for 15 min, each sample was dried before use. The Ti
discs were grouped into four different treatment groups,
each group consisting of n 5 4 four pieces for each inde-
pendent experiment. The first group was the control group:
after the cleaning and drying of the discs, no chemical
treatment was applied. The others were immersed into a
solution of one of the dental implant surface decontami-
nating agents for 60 min, the following chemical agents were
used in this study: 0.1% chlorhexidine digluconate (second
group; Corsodyl®, GlaxoSmithKline, Brentford. UK), 10%
PVP-iodine solution (third group; Betadine®, Purdue
Pharma LP, Stamford, CT, USA) and 40 w/w% citric acid
monohydrate solution prepared in deionized water (fourth
group; Thermo Fisher Scientific, Hampton, VI, USA). The
discs were always handled with Ti forceps to avoid
contamination of the Ti surface with other metals [18]. For
each round of experiments, n 5 16 Ti samples were used:
n 5 12 Ti discs were immersed into one of the prophylactic
agents, and n 5 4 samples were left untreated (control
group) but went through the same cleaning procedure.
Three independent experiments were performed, with alto-
gether n5 48 titanium discs. After 60 min of immersion, the
samples were washed with ultrapure water (Thermo Fisher
Scientific, Hampton, VI, USA) and dried.
The application time of different decontamination so-
lutions corresponds to different time periods or effects of
accumulated use under clinical circumstances: for CHX, the
dose corresponds to 4 months of regular use, for citric acid,
it corresponds to 12 clinical uses, while for PVP-iodine
treatment, the dose was equivalent for 20 clinical uses. This
was calculated based on available literature data and the
manufacturer's instructions [26–28]. All treated and control
discs were steam-sterilized at 160 C for 45 min and stored in
closed packaging until use. The experiments were always
performed within packaging expiration time, which was 14
days [19].
Preparation of Porphyromonas gingivalis inoculum
Columbia agar base (Oxoid, Basingstoke, United Kingdom)
supplemented with 5 v/v% cattle blood, hemin and vitamin
K1 was used for the culturing of P. gingivalis. Fresh colonies
of P. gingivalis strain ATCC 33277, incubated in an atmo-
sphere of 90% N2, 5% H2 and 5% CO2 in an anaerobic
environment for 48 h (Concept 400 anaerobic incubator,
Biotrace International Plc., UK) were suspended in reduced
Brain Heart Infusion (BHI) broth (Oxoid, Basingstoke,
United Kingdom) and used after gentle dispersion (at a
bacterial cell density of McFarland 1.0 dilution). 2 mL ali-
quots of these bacterial suspensions were immediately plated
onto 24-well sterile microtiter plates, containing the
different Ti discs from the respective groups. Every second
day, the bacterial suspension was changed for a fresh solu-
tion. After 6 days of anaerobic incubation (under 90% N2,
5% H2 and 5% CO2 in the abovementioned anaerobic
incubatior), the samples were removed from the bacterial
culture.
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MTT assay
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide] assay was used for the determination of
bacterial growth and viability, during which the activity of
mitochondrial dehydrogenases in living bacterial cells is
measured, corresponding to a color change (due to the
reduction of yellow MTT into purple, water-insoluble
tetrazolium salt), which may be quantifiable with spectro-
photometric methods [29]. Cells were seeded into 48-well
culture plates at a density of 3,000 or 104 cells/well and
grown on Ti discs in culture media for 24 or 72 h, respec-
tively. The supernatant was removed and replaced with 0.5
mg/mL MTT solution (Sigma-Aldrich GmbH, Germany) in
RPMI medium without phenol red. After incubation for 4 h
at 37 8C, the medium was gently removed from each well
and the crystallized dye was solubilized with 2% sodium
dodecyl sulfate (SDS) and 0.04 mM HCl in absolute iso-
propanol [30]. The optical density of was determined at 540/
630nm with a Multiscan EX spectrophotometer (Thermo
Labsystems, Vantaa, Finland) and Ascent Software (Thermo
Labsystems, Vantaa, Finland).
Scanning Electron Microscopy (SEM) studies
After treatment with the disinfectant solutions and bac-
terial incubation, the Ti discs were treated with the
following method for fixation: dehydration of the surface
bacteria and bacterial biofilm, first by rinsing with ethanol
solutions of increasing concentrations, (30–50–70–100 V/
V%) then by a mixture of ethanol and acetone (90–10, 70–
30, 50–50, 30–70, 10–90, 100% of acetone). Critical point
drying (determined by an SPI 1320 apparatus) was
applied, after which the discs were gold-coated by means
of an Edwards sputter coater and subjected to scanning
electron microscopy (SEM) with JEOL JSM-7100F/LV
instrument.
Statistical analysis
The results of the measurements were collected in a
spreadsheet file Microsoft Excel 2013 (v15.0) (Microsoft
Corporation, Redmond, WA, USA). Statistical analysis was
performed using Statistica for Windows 10.0 (Statsoft, Tulsa,
OK, USA). Besides the descriptive statistics, groups defined
by the treatment of the chemical agents were compared with
one-way ANOVA (with Tukey post hoc analysis). P values
<0.05 were considered statistically significant.
RESULTS
Assessment of biofilm-formation by SEM studies
Various amounts of biofilm evolved on the Ti disc surfaces
depending on the treatment applied (see groups 1–4). This
is well illustrated by the SEM images taken at day 6. Fig. 1
shows the surface of a control disc after 6 days of incu-
bation with P. gingivalis. Some of the bacteria occurred in
multiple layers, in an interconnected manner, in addition a
biofilm has noticeably formed. Fig. 2 shows the surface of a
disc treated with chlorhexidine and incubated with P.
gingivalis for 6 days. Bacterial biofilm could be observed in
several layers on the surface, which is not continuous. SEM
analysis shows no substantial difference in comparison
with the control group. Fig. 3 shows a SEM image of the
Fig. 1. Scanning electron microscope (SEM) image of an untreated control disc. Magnification: 2,0003
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surfaces of a Ti disc after treatment with citric acid-mon-
ohydrate and incubation with the model pathogen: some
bacteria formed multiple layers of biofilm. Fig. 4 shows a Ti
surface after treatment with 10% solution of PVP-iodine:
note that the bacterial growth is negligible as compared to
the rest of the treatments. Active reproduction of the
bacteria was observed and the formation of a monolayer
has not yet started.
Fig. 3. Scanning electron microscope (SEM) image of a Ti disc treated with citric acid monohydrate and incubated with Porphyromonas
gingivalis for 6 days. Bacterial growth is observable in multiple layers. Magnification: 2,0003
Fig. 2. Scanning electron microscope (SEM) image of a Ti disc treated with chlorhexidine and incubated with Porphyromonas gingivalis for 6
days. Bacterial growth is readily observable. Magnification: 2,0003
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Assessment of the bacterial cell viability after different
treatments
Significant differences in the quantity of P. gingivalis could
be observed after 6 days of incubation. A numerical, but not
statistically significant (P5 0.066) decrease in the amount of
living bacteria was observed in the group treated with the
PVP-iodine solution as compared to the control group. The
CHX-treated group presented with significantly higher cell
counts, as compared to the PVP-iodine-treated group (P 5
0.032), while this was not observed compared to the control
group and citric acid-treated group (P > 0.05; Fig. 5). Results
by measurement are presented in Table 1.
DISCUSSION
During our present study, the effects of different disinfec-
tants were assessed on bacterial cell viability on Ti discs,
where P. gingivalis was chosen as a model microorganism.
The results obtained during our experiments confirmed our
hypothesis that the use of different chemical agents has a
substantial influence on bacterial growth on the dental
material. Our in vitro results suggest that the right choice of
disinfectant influences the resistance of Ti implant surfaces
to bacterial growth, which should be considered a clinically
important finding. In addition, chemical disinfection alone
was found to be ineffective (no statistically significance was
shown), which, however, is in accordance with the literature.
Considering both the quantitative (MTT assay) and
qualitative (SEM studies) results of this study, the most
effective treatment modality in this study was PVP-iodine.
Several studies in the literature have reported on the highly
substantive nature of CHX on titanium surfaces [31]; in
their study, Kotsakis et al. concluded that the use of CHX is
not recommended for the decontamination of titanium
surfaces [32]. In contrast to CHX, exposition of osteoblast
cell lines to PVP-iodine has been reported to lead to an
initial decrease, but an increase of the mineralization activity
over a longer period of time [33]. Furthermore, PVP-iodine
has a broad antibacterial spectrum, including bacteria that
Fig. 4. Scanning electron microscope (SEM) image of a Ti disc treated with povidone-iodine and incubated with Porphyromonas gingivalis
for 6 days. Bacteria are present, but to a notably lesser extent than on the citric acid- and CHX-treated and control surfaces. Magnification:
2,0003
Fig. 5. Bacterial cell viability on the surface of Ti discs after 6 days
of incubation with Porphyromonas gingivalis
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have been associated with periodontal and peri-implant
microflora [34]. The idea of using citric acid to treat peri-
implantitis was based on empirical clinical success with its
use in treating periodontitis, rather than results of systematic
scientific research [35]. This positive effect of citric acid has
been widely observed in periodontitis, revealing that this
chemical agent can stimulate cementogenesis and may also
enhance reattachment to the root surface [36–39]. In addi-
tion, citric acid has been shown to inhibit the growth of
bacteria on root surfaces affected by periodontal diseases
[40]. Although citric acid has shown great capacity for
implant surface decontamination, more studies are needed
to test and verify its efficacy [5].
The use of chlorhexidine gluconate (CHX) is well
documented in periodontal therapy and we included this
agent in our studies due to its widespread use; its use has
been proven to be effective in reducing periodontal
inflammation and in controlling subgingival plaque forma-
tion [41]. This agent is thought to be a non-specific anti-
bacterial agent and it directly interferes with the cell walls of
bacteria, resulting in cell lysis [42, 43]. The use of CHX is
advantageous due to its substantivity, which allows the agent
to be absorbed into hard and soft oral tissues and be released
over time. This effect can last up to 12 h. Nonetheless,
several disadvantages are related to its use, like taste alter-
ations, staining, and slight increase in calculus formation
[43]. CHX have been widely used to treat peri-implantitis,
but no study so far have managed to demonstrate the su-
periority of chlorhexidine over other decontamination
agents [5]. In several previous studies on non-surgical peri-
implantitis therapy, CHX was preferentially used as an
antiseptic adjuvant, with variable clinical success [44–48].
Patients received a one-stage full-mouth scaling with or
without chlorhexidine led to an improvement of the clinical
parameters and a temporary reduction of the microflora at
implants with mucositis [42]. More importantly, Kotsakis
et al. have recently demonstrated that CHX is able to notably
change the physicochemical properties of the titanium
implant surfaces and markedly inhibit the activity of oste-
oblasts [32]. This raises the possibility of cytotoxicity, which
questions the use of chlorhexidine in the treatment of peri-
implant disease.
PVP-iodine is a topically used antiseptic agent with a
broad antibacterial spectrum covering a multitude perio-
dontopathogenic species. Lanker Klossner et al. [49]
demonstrated that long-term use of PVP-iodine does not
cause any bacterial resistance; however, Sahrmann et al.
found that PVP-iodine reapplied frequently during scaling
and root planning might enhance pocket depth reduction
in initially deep pockets [34] and the adjunctive use of
PVP-iodine during scaling and root planning may increase
the clinical pocket depth reduction [35]. Another study
showed the application of PVP-iodine gel in periodontal
pockets allows a prolonged remnant effect compared with
the solution PVP-iodine formula [36]. Although the effi-
ciency of PVP-iodine seemed to be superior in comparison
to citric acid based on the SEM findings, the statistical
analyses did not show significant difference between these
two agents.
During our studies, P. gingivalis was chosen as a model
microorganism for antibacterial and biofilm-formation
studies. The dental biofilm is a natural ecosystem, bacteria
predominantly reside in structured, surface-attached com-
munities embedded in a self-produced, extracellular matrix
[24, 50, 51]. The oral Gram-negative obligate anaerobic
bacterial species P. gingivalis is typically considered a so-
called “late colonizer” of subgingival biofilms and has been
related to several destructive periodontal diseases, including
periodontitis and peri-implantitis [50]. The pathogenicity of
P. gingivalis is reflected in a lot of different important
virulence factors involved in tissue colonization and
destruction, and interference with host defense systems.
Peri-implant inflammation and lesions are of multifactorial
nature, but it is a fact unequivocally supported by the
literature that P. gingivalis plays a leading role in both cases
[24, 50, 51]. In a previous study, it was demonstrated that P.
gingivalis has the ability to colonize titanium surface in
multiple interconnected layers, forming a biofilm, namely a
polysaccharide coat (glycocalyx), which is a protective layer
for the bacterial population [52, 53].






Measurement 1 0.093 0.072 0.196 0.108
Measurement 2 0.109 0.085 0.169 0.133
Measurement 3 0.114 0.093 0.240 0.125
Measurement 4 0.083 0.070 0.094 0.043
Measurement 5 0.076 0.064 0.064 0.044
Measurement 6 0.066 0.090 0.076 0.043
Measurement 7 0.084 0.061 0.093 0.071
Measurement 8 0.069 0.066 0.089 0.062
Measurement 9 0.063 0.060 0.085 0.079
Average 0.084 0.073 0.123 0.079
SD 0.018 0.013 0.06 0.04
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CONCLUSION
During our experiments, a comparison of different chemical
disinfectant treatment protocols was performed with the aim
of assessing the efficacy as antibacterial agents in clinical
situations. The proliferation of P. gingivalis was measured,
which is a pathogen, which plays a crucial role in the
development of peri-implant inflammations. During the
comparison we did find significant differences in microbial
growth on the treated titanium discs, compared to the
control group. However when compared to the chlorhexi-
dine-digluconate-treated group, disk treated with PVP-
iodine showed a marked reduction in bacterial count. Our
results suggest that PVP-iodine is superior to CHX for the
chemical disinfection of titanium surfaces in the context of
P. gingivalis contamination. P. gingivalis still has a crucial
role as a periodontopathogen, therefore studies regarding
the response of this specific pathogen to various treatments
does provide clinically useful knowledge to help combat
periodontitis and peri-implantitis in the future.
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